Showing results (1-10 of 149) with videos related to
Sort By:
Pageof 15
Diabetes Technology & Therapeutics|June 15, 2011
Evolution of devices in diabetes managementAlfred Penfornis, Estelle Personeni, Sophie BorotSurgery|February 16, 2010
Results of cryopreserved parathyroid autografts: a retrospective multicenter studySophie Borot, Valérie Lapierre, Bruno Carnaille, et al.Annales D'Endocrinologie|November 14, 2012
Pituitary function and glucose tolerance in a family with a PAX6 mutationLucie Hergott-Faure, Sophie Borot, Colette Kleinclauss, et al.Diabetes Technology & Therapeutics|February 5, 2011
Performance of a new reusable insulin penAlfred PenfornisBiologie Aujourd'Hui|July 25, 2022
[One hundred years after the discovery of insulin: a new revolution for patients living with type 1 diabetes?]Sophie BorotDiabetes & Metabolism|February 8, 2025
Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital centerSylvie Picard, Blandine Courbebaisse, Joëlle Dupont, et al.Journal of Diabetes Science and Technology|October 5, 2025
Use of the Glycemia Risk Index at Hybrid Closed-Loop Initiation to Predict Combined International Glucose Targets at 12 Months: Results From the CIRDIA Study GroupSylvie Picard, Joëlle Dupont, Fabienne Amiot-Chapoutot, et al.Journal of Diabetes Science and Technology|August 1, 2014
Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studiesSophie Borot, Sylvia Franc, Justine Cristante, et al.Diabetes Research and Clinical Practice|July 20, 2011
GLP-1 receptor agonists todayMichel Marre, Alfred PenfornisDiabetes Technology & Therapeutics|August 22, 2008
Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levelsAlfred Penfornis, Kristian HorvatPageof 15